BioSpace News Archive

Business

NYC Continues Quest to Become Premiere Biotech Hub

For the last several years New York has been building itself up to be the biggest biotech hub on the east coast.

June 13, 2018
·
4 min read
·
Alex Keown
Pharm Country

Alcohol-Addiction Drug Seems to Help Retroviral Compliance and Suppress HIV Levels

Researchers at Yale University recently published research that found patients receiving a drug for alcohol addiction aided in retroviral treatment compliance and seemed to help suppress HIV levels.

June 13, 2018
·
3 min read
·
Mark Terry
Drug Development

vTv Alzheimer’s Drug Fails Again But Company Sees Hope in Additional Development

vTv Therapeutics reported the second part of its Phase III Alzheimer’s disease study failed to meet co-primary efficacy endpoints.

June 13, 2018
·
2 min read
·
Alex Keown
Drug Development

Celgene Admits It Screwed Up on Multiple Sclerosis Drug Application … Sort Of

This year the FDA issued a Refusal to File letter regarding its New Drug Application (NDA) for its multiple sclerosis drug ozanimod. The finger is pointed at its California subsidiary, Receptos for the failure.

June 13, 2018
·
2 min read
·
Mark Terry
2 Studies: CRISPR Potentially Linked to Cancer Risk

Now, two studies published in Nature Medicine suggest that CRISPR may lead to cancer unintentionally.

June 13, 2018
·
3 min read
·
Mark Terry
Business

Eisai Plans Invests $100M in Genetics Guided Dementia Discovery Facility in Cambridge, Mass.

Eisai Inc. is adding to its arsenal aimed at combating dementia. The company will launch the Eisai Center for Genetics Guided Dementia Discovery.

June 13, 2018
·
2 min read
·
Alex Keown
Policy

Massachusetts Attorney General Targets Purdue Pharmaceuticals in Lawsuit

Purdue Pharmaceuticals is facing a new legal challenge over its OxyContin marketing practices.

June 13, 2018
·
2 min read
·
Alex Keown
Drug Development

Flex Pharma Shutters Phase II ALS Program and Cut 60% of Workforce

Flex Pharma announced in a Corporate Update that it is closing an ongoing Phase II clinical trial of FLX-787 in ALS and CMT while shifting its strategy to focus on other approaches.

June 13, 2018
·
2 min read
·
Mark Terry
Policy

FDA Commissioner Proposes Licensing Model for Antimicrobial Drugs

Food and Drug Administration chief Scott Gottlieb is making a pitch to change the reimbursement model for antimicrobial drugs that target multidrug-resistant infections.

June 13, 2018
·
3 min read
·
Alex Keown
Canada’s scientists can pitch projects that bridge artificial intelligence, health research

June 13, 2018
·
1 min read